Literature DB >> 17372694

The influence of hyperlipoproteinemia on in vitro distribution of amiodarone and desethylamiodarone in human and rat plasma.

Anooshirvan Shayeganpour1, Stephen D Lee, Kishor M Wasan, Dion R Brocks.   

Abstract

PURPOSE: To study the effect of hyperlipoproteinemia on in vitro distribution of amiodarone (AM) and its prevalent metabolite desethylamiodarone (DEA) in human and rat plasma.
MATERIALS AND METHODS: Human and rat normolipidemic (NL) and hyperlipidemic (HL) plasma were spiked with AM and DEA. The fractions (high and low density lipoproteins, triglyceride rich lipoproteins and lipoprotein deficient plasma) were separated using ultracentrifugation.
RESULTS: Human and rat displayed similar patterns in terms of association of AM and DEA in NL plasma, in which the highest and lowest associations were observed in lipoprotein deficient (LPDP) and triglyceride (TRL) rich plasma fractions, respectively. In HL a substantial shift was observed in partitioning of AM and DEA mostly to TRL. The shift of AM and DEA into TRL fraction of HL plasma was more drastic for rat than human. In HL, association of AM with rat LPDP and HDL fractions were 10 and 26-fold lower than in the corresponding human fractions, respectively. The DEA:AM ratio in rat, but not human, was significantly affected by HL.
CONCLUSION: HL caused a major shift of AM and DEA to TRL fraction in both species. The findings were consistent with the higher AM concentrations previously noted in HL rats given the drug.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17372694     DOI: 10.1007/s11095-006-9186-z

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  19 in total

1.  A liquid chromatography-mass spectrometry assay method for simultaneous determination of amiodarone and desethylamiodarone in rat specimens.

Authors:  Anooshirvan Shayeganpour; Vishwa Somayaji; Dion R Brocks
Journal:  Biomed Chromatogr       Date:  2007-03       Impact factor: 1.902

2.  Pharmacokinetics of Amiodarone in hyperlipidemic and simulated high fat-meal rat models.

Authors:  Anooshirvan Shayeganpour; Andrew S Jun; Dion R Brocks
Journal:  Biopharm Drug Dispos       Date:  2005-09       Impact factor: 1.627

3.  Effects of desethylamiodarone on the electrocardiogram in conscious freely moving animals: pharmacokinetic and pharmacodynamic modeling using computer-assisted radio telemetry.

Authors:  J Kharidia; N D Eddington
Journal:  Biopharm Drug Dispos       Date:  1996-03       Impact factor: 1.627

4.  Determination of the enzyme(s) involved in the metabolism of amiodarone in liver and intestine of rat: the contribution of cytochrome P450 3A isoforms.

Authors:  Anooshirvan Shayeganpour; Ayman O S El-Kadi; Dion R Brocks
Journal:  Drug Metab Dispos       Date:  2005-10-04       Impact factor: 3.922

Review 5.  Role of plasma lipoproteins in modifying the biological activity of hydrophobic drugs.

Authors:  K M Wasan; S M Cassidy
Journal:  J Pharm Sci       Date:  1998-04       Impact factor: 3.534

6.  Enhanced amphotericin B nephrotoxicity in intensive care patients with elevated levels of low-density lipoprotein cholesterol.

Authors:  K M Wasan; J S Conklin
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

7.  Competitive displacement of clozapine from plasma proteins in normolipidemic and hyperlipidemic plasma samples: clinical implications.

Authors:  Ric M Procyshyn; Tiffany Ho; Kishor M Wasan
Journal:  Drug Dev Ind Pharm       Date:  2005-05       Impact factor: 3.225

8.  Elevation of high-density lipoprotein cholesterol in humans during long-term therapy with amiodarone.

Authors:  P T Pollak; M H Tan
Journal:  Am J Cardiol       Date:  1999-01-15       Impact factor: 2.778

9.  Pharmacokinetics, distribution in serum lipoproteins and tissues, and renal toxicities of amphotericin B and amphotericin B lipid complex in a hypercholesterolemic rabbit model: single-dose studies.

Authors:  K M Wasan; A L Kennedy; S M Cassidy; M Ramaswamy; L Holtorf; J W Chou; P H Pritchard
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

10.  Binding of amiodarone by serum proteins and the effects of drugs, hormones and other interacting ligands.

Authors:  M R Lalloz; P G Byfield; R M Greenwood; R L Himsworth
Journal:  J Pharm Pharmacol       Date:  1984-06       Impact factor: 3.765

View more
  3 in total

1.  Effect of experimental hyperlipidaemia on the electrocardiographic effects of repeated doses of halofantrine in rats.

Authors:  Jigar P Patel; Dion R Brocks
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

Review 2.  Lipoprotein Drug Delivery Vehicles for Cancer: Rationale and Reason.

Authors:  Jaideep Chaudhary; Joseph Bower; Ian R Corbin
Journal:  Int J Mol Sci       Date:  2019-12-15       Impact factor: 5.923

3.  Increased serum amiodarone concentration in hypertriglyceridemic patients: Effects of drug distribution to serum lipoproteins.

Authors:  Naoaki Hashimoto; Kosuke Doki; Satoru Kawano; Kazutaka Aonuma; Masaki Ieda; Masato Homma
Journal:  Clin Transl Sci       Date:  2021-11-25       Impact factor: 4.689

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.